New pill aims to protect lungs in progressive scarring disease
Disease control
Recruiting now
This study is testing whether a new oral medication called buloxibutid can help slow the decline of lung function in people with idiopathic pulmonary fibrosis (IPF). Over 52 weeks, 360 participants will take either one of two doses of the drug or a placebo pill, while researchers…
Phase: PHASE2 • Sponsor: Vicore Pharma AB • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC